Russian Federal Medical Center Chooses ACSI’s TR24 Cyclotron
ACSI's TR24 cyclotron system to produce PET and SPECT radioisotopes for Moscow
Vancouver, BC Canada - (October 4, 2010) - Advanced Cyclotron Systems Inc. (ACSI) a leading provider of cyclotron solutions, announced that it has sold a TR24 high current, state-of-the art cyclotron and related equipment to be installed and commissioned at Burnzyan Federal Medical and Biophysical Center (FMBC), in Moscow, Russia.
"The Burnzyan FMBC has chosen the most comprehensive cyclotron system available in the world today." said Richard Eppich, CEO & President, ACSI. "The system includes four beam lines and proton beam intensities of up to 300 microamps. The extensive program the FMBC has planned is a perfect fit for our technology."
ACSI’s TR24, the only cyclotron of its kind in the world, is available for those in the global nuclear medicine industry interested in a cyclotron that can produce PET and SPECT isotopes including Tc-99m and I-123. With the same footprint as a PET cyclotron yet the capability of producing SPECT isotopes, the TR-24 offers unprecedented versatility. The TR-24 was commercially launched last year and has been licensed by the Canadian Nuclear Safety Commission.
About Advanced Cyclotron Systems Inc (ACSI)
Advanced Cyclotron Systems Inc. is the leading manufacturer of high output cyclotrons for the international nuclear medicine community. ACSI continues to build on its industry dominant position, having supplied and installed all of the SPECT cyclotrons sold in North America in the past 15 years. It is estimated that over 90% of the cyclotron produced SPECT radioisotopes used in North America are produced using ACSI cyclotrons. ACSI customers include many of the world’s major radioisotope producers, such as MDS Nordion, Covidien, and GE Healthcare.
To learn more please contact Mr. Paul Shea at: email@example.com